I was unable to extract the text from the PDF directly - the document is image-based and the tools available (OCR libraries, analyse_media, fetch_image) could not read the local image files in this session. However, the PDF filename clearly says GBS (Guillain-Barré Syndrome), and based on the document structure (38 pages, physiotherapy case format), I can provide you a complete, clinically accurate case presentation framework for GBS that matches exactly what a physiotherapy case file contains. If you can share the specific patient details typed out, I can personalize everything precisely.
CASE PRESENTATION: GUILLAIN-BARRÉ SYNDROME (GBS)
Physiotherapy Case Presentation
PART 1 - PATIENT IDENTIFICATION
| Field | Details |
|---|
| Name | [As per case file] |
| Age | [As per case file - GBS peaks in 15-35 yrs and >50 yrs] |
| Sex | [As per case file] |
| Occupation | [As per case file] |
| Address | [As per case file] |
| Date of Admission | [As per case file] |
| Date of Assessment | [As per case file] |
| Referred By | Neurology Department / Physician |
| Diagnosis | Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy - AIDP) |
| Ward / Bed No. | [As per case file] |
PART 2 - HISTORY
2.1 Chief Complaints
(In order of severity and onset)
- Progressive ascending weakness of bilateral lower limbs, spreading to upper limbs
- Difficulty in walking / inability to walk
- Tingling and numbness (paresthesia) in hands and feet
- Pain in lower limbs / back
- Difficulty in climbing stairs / rising from floor
- Fatigue on minimal exertion
- ± Difficulty in breathing (in severe cases)
- ± Difficulty in swallowing / facial weakness (bulbar involvement)
2.2 History of Present Illness (HPI)
The patient presented with a history of rapid, progressive, ascending flaccid weakness beginning in the lower extremities and progressing cranially over days to 2-4 weeks. The weakness was typically preceded by a prodromal illness 2-4 weeks prior - most commonly an upper respiratory tract infection (URTI) or acute gastroenteritis (AGE), frequently associated with Campylobacter jejuni, cytomegalovirus (CMV), Epstein-Barr virus (EBV), or Mycoplasma pneumoniae.
Typical timeline:
- Week 1-2 before admission: Fever, diarrhea / respiratory infection
- Day 1-3 of neurological onset: Tingling/numbness in toes and fingers, mild leg weakness
- Day 3-7: Progressive bilateral leg weakness, inability to walk unassisted
- Day 7-14: Weakness extending to trunk and upper limbs, areflexia noted
- At admission: Complete or near-complete flaccid paralysis of all four limbs (quadriparesis/quadriplegia), absent deep tendon reflexes throughout, possible respiratory involvement
The progression of weakness is symmetrical, ascending, and associated with loss of deep tendon reflexes (areflexia). The patient may also report autonomic symptoms such as fluctuations in heart rate, blood pressure lability, urinary retention, or excessive sweating.
No history of:
- Fever at time of neurological onset
- Bladder/bowel incontinence (differentiates from spinal cord pathology)
- Cranial nerve involvement at onset (though may develop)
- Prior similar episodes
2.3 History of Past Illness (HPI)
- Antecedent illness: H/o viral URTI / gastroenteritis 2-4 weeks prior (most common trigger)
- Previous neurological illness: None significant
- Previous hospitalizations: None / as per case file
- History of similar episodes: None (GBS is typically a monophasic illness)
- History of trauma: Absent
- Surgical history: None relevant
- Vaccination history: H/o recent vaccination (influenza, COVID-19) in some cases can trigger GBS (rare association - 1-2 per million doses)
2.4 Past Medical History
| System | Details |
|---|
| Diabetes Mellitus | Absent / as per case file |
| Hypertension | Absent / as per case file |
| Cardiac Disease | Absent |
| Respiratory Disease | Absent (pre-morbid) |
| Thyroid Disorders | Absent |
| Autoimmune Disorders | Absent (though GBS itself is autoimmune) |
| Malignancy | Absent |
| HIV / Immunocompromised | Rule out (can predispose) |
| Renal / Hepatic Disease | Absent |
2.5 Family History
- No family history of similar neurological illness
- No hereditary neuropathies (Charcot-Marie-Tooth disease ruled out)
- No autoimmune diseases in first-degree relatives
2.6 Personal / Social History
| Field | Details |
|---|
| Marital Status | [As per case file] |
| Education | [As per case file] |
| Occupation | [As per case file] |
| Living situation | [As per case file - relevant for discharge planning] |
| Home environment | Ground floor / stairs / accessibility |
| Smoking | [As per case file] |
| Alcohol | [As per case file] |
| Diet | Vegetarian / Non-vegetarian |
| Sleep | Disturbed due to pain and anxiety |
| Hobbies / Activities | [Relevant for goal-setting] |
| Support system | Family / caregiver availability for home PT |
2.7 Socioeconomic History
| Field | Details |
|---|
| Socioeconomic status | Middle / Lower-middle class (as per case file) |
| Monthly family income | [As per case file] |
| Occupation / Employment | [Note impact of disability on livelihood] |
| Health insurance | [As per case file] |
| Access to rehabilitation | [Distance from hospital, transport availability] |
| Caregiver support | [Critical for long-term compliance] |
| Functional dependency | Currently fully/partially dependent for ADLs |
2.8 Drug History / Medication History
Current medications (typically prescribed in GBS):
| Drug | Indication |
|---|
| IV Immunoglobulin (IVIg) 0.4 g/kg/day x 5 days | Disease-modifying treatment |
| OR Plasmapheresis (5 sessions) | Alternative to IVIg |
| Low Molecular Weight Heparin (LMWH) | DVT prophylaxis (immobilized patient) |
| Gabapentin / Pregabalin | Neuropathic pain |
| Paracetamol / NSAIDs | Musculoskeletal pain |
| Proton Pump Inhibitors | GI protection |
| Stool softeners | Constipation (autonomic dysfunction) |
Drug Allergies:
- NKDA (No Known Drug Allergies) - as per case file
- Any specific allergies noted: [As per case file]
Note for physiotherapy: Gabapentin/pregabalin may cause dizziness and sedation - important to monitor during exercise sessions. LMWH injection sites to be avoided during manual therapy.
PART 3 - CLINICAL EXAMINATION
3.1 General Examination
| Parameter | Findings |
|---|
| Consciousness | Conscious, alert, and oriented |
| Cooperation | Cooperative |
| Built | Moderate / as per case file |
| Nourishment | Adequately nourished |
| Pallor | Absent |
| Icterus | Absent |
| Cyanosis | Absent |
| Clubbing | Absent |
| Lymphadenopathy | Absent |
| Edema | Pedal edema may be present (due to immobility) |
| Vital Signs | BP: labile (autonomic dysfunction), HR: may vary, RR: monitor for respiratory compromise, SpO2: ≥ 95% |
| Temperature | Afebrile |
3.2 Respiratory Examination
- Chest expansion: Reduced bilaterally
- Breath sounds: Vesicular, may show reduced air entry at bases
- SpO2: Within normal limits unless respiratory muscles involved
- Forced Vital Capacity (FVC): Monitor for "20/30/40 rule" - intubation considered when FVC <20 mL/kg, MIP < -30 cmH2O, MEP < 40 cmH2O
- Cough strength: Weak / moderate (monitor for aspiration risk)
3.3 Neurological Examination
3.3.1 Motor System
Tone:
| Limb | Tone |
|---|
| Bilateral Upper Limbs | Hypotonia (flaccid) |
| Bilateral Lower Limbs | Hypotonia (flaccid) |
| Trunk | Reduced |
Muscle Power (MRC Scale 0-5):
| Muscle Group | Right | Left |
|---|
| Upper Limbs | | |
| Shoulder abductors (Deltoid) | 3/5 | 3/5 |
| Elbow flexors (Biceps) | 3/5 | 3/5 |
| Elbow extensors (Triceps) | 3/5 | 3/5 |
| Wrist extensors | 2/5 | 2/5 |
| Finger flexors | 2/5 | 2/5 |
| Intrinsics | 1/5 | 1/5 |
| Lower Limbs | | |
| Hip flexors (Iliopsoas) | 1/5 | 1/5 |
| Hip extensors (Gluteus maximus) | 1/5 | 1/5 |
| Hip abductors | 2/5 | 2/5 |
| Knee extensors (Quadriceps) | 1/5 | 1/5 |
| Knee flexors (Hamstrings) | 1/5 | 1/5 |
| Ankle dorsiflexors (Tibialis anterior) | 0/5 | 0/5 |
| Ankle plantarflexors (Gastrocnemius) | 0/5 | 0/5 |
| Trunk | | |
| Abdominals | 2/5 | 2/5 |
(Grades are representative - record actual findings from case file)
3.3.2 Deep Tendon Reflexes
| Reflex | Right | Left |
|---|
| Biceps (C5-C6) | Absent | Absent |
| Brachioradialis (C5-C6) | Absent | Absent |
| Triceps (C7) | Absent | Absent |
| Knee (L3-L4) | Absent | Absent |
| Ankle (S1) | Absent | Absent |
Areflexia (absent reflexes throughout) is the hallmark of GBS.
3.3.3 Plantar Response
- Bilateral: Flexor (downgoing) - extensor response rare in LMN lesion
3.3.4 Sensory Examination
| Modality | Finding |
|---|
| Light touch | Reduced in distal extremities (glove and stocking distribution) |
| Pain (pin-prick) | Hyperalgesia / reduced distally |
| Temperature | Reduced distally |
| Vibration (128 Hz tuning fork) | Absent at toes, reduced at ankles |
| Proprioception (Joint position sense) | Impaired at interphalangeal joints |
| Two-point discrimination | Impaired |
3.3.5 Cranial Nerve Examination
| Nerve | Finding |
|---|
| CN VII (Facial) | May show bilateral facial weakness (Miller Fisher variant) |
| CN IX/X (Glossopharyngeal/Vagus) | Bulbar involvement - dysphagia, dysarthria in severe cases |
| CN VI (Abducens) | Ophthalmoplegia in Miller Fisher variant |
| Others | Typically intact |
3.3.6 Coordination
- Finger-nose test: Impaired (due to weakness and proprioceptive loss)
- Heel-shin test: Unable to perform (due to weakness)
3.3.7 Gait
- Current status: Unable to walk / bed-bound (at admission)
- May progress to needing walker/crutches as recovery proceeds
3.4 Functional Assessment
Functional Independence Measure (FIM) - Admission Score
| Domain | Score (1=Total Assist, 7=Independent) |
|---|
| Eating | 3-4 |
| Grooming | 2-3 |
| Bathing | 1-2 |
| Dressing upper body | 2-3 |
| Dressing lower body | 1-2 |
| Toileting | 1-2 |
| Bladder management | 3-4 |
| Bowel management | 3-4 |
| Bed transfers | 1-2 |
| Toilet transfer | 1-2 |
| Bath transfer | 1-2 |
| Walk/wheelchair | 1 |
| Stairs | 1 |
| Comprehension | 7 |
| Expression | 7 |
| Social interaction | 7 |
| Problem solving | 7 |
| Memory | 7 |
| Total FIM Score | ~40-50 / 126 (severe disability) |
GBS Disability Scale (Hughes Scale)
| Grade | Description |
|---|
| 0 | Healthy |
| 1 | Minor symptoms/signs, capable of manual work |
| 2 | Able to walk 10 m without walking aid |
| 3 | Able to walk 10 m with walking aid |
| 4 | Bed-/chair-bound (Typical at admission) |
| 5 | Requires assisted ventilation |
| 6 | Dead |
Patient typically presents at Grade 3-4 on Hughes Scale.
PART 4 - INVESTIGATIONS
4.1 Routine Blood Investigations
| Investigation | Findings in GBS |
|---|
| CBC | Usually normal; mild leukocytosis possible post-infection |
| ESR | Mildly elevated |
| CRP | May be elevated (inflammatory marker) |
| Blood glucose | Normal |
| Renal function tests | Normal |
| Liver function tests | Normal |
| Serum electrolytes | Monitor sodium (SIADH possible) |
| Thyroid function | Normal (rule out thyroid myopathy) |
4.2 Cerebrospinal Fluid (CSF) Analysis - LUMBAR PUNCTURE
| Parameter | Normal | GBS Finding |
|---|
| Appearance | Clear | Clear |
| Pressure | Normal | Normal/slightly elevated |
| Proteins | 15-45 mg/dL | ELEVATED (>45 mg/dL; often 100-1000 mg/dL) |
| Cells | <5 cells/mm³ | <10 cells/mm³ (Albuminocytological dissociation) |
| Glucose | Normal | Normal |
Albuminocytological dissociation (high protein + normal cells) is the classic CSF finding in GBS.
4.3 Nerve Conduction Study (NCS) / Electromyography (EMG)
Most important diagnostic investigation:
| Parameter | AIDP (most common) | AMAN |
|---|
| Motor nerve conduction velocity | Reduced (<60% normal) | Normal/near-normal |
| Distal motor latency | Prolonged | Normal/mildly prolonged |
| F-wave latency | Prolonged/absent | Prolonged/absent |
| CMAP amplitude | Mildly reduced | Severely reduced |
| Sensory NCS | Absent/reduced | Normal |
| EMG | Reduced recruitment | Denervation potentials |
4.4 Anti-ganglioside Antibodies
| Antibody | Associated Variant |
|---|
| Anti-GM1 | AMAN / AIDP |
| Anti-GD1b | Ataxic GBS |
| Anti-GQ1b | Miller Fisher Syndrome |
| Anti-GD1a | AMSAN |
4.5 Imaging
| Investigation | Indication | Findings |
|---|
| MRI Spine (with contrast) | Rule out cord compression / transverse myelitis | Enhancement of nerve roots (cauda equina) in GBS |
| Chest X-ray | Monitor respiratory status, aspiration pneumonia | Usually normal at onset |
| ECG | Autonomic monitoring | Arrhythmias, sinus tachycardia |
4.6 Pulmonary Function Tests
- FVC (Forced Vital Capacity): Baseline and serial monitoring
- MIP (Maximum Inspiratory Pressure): Reflects diaphragm strength
- MEP (Maximum Expiratory Pressure): Reflects cough strength
- Peak Expiratory Flow (PEF): Serial monitoring
PART 5 - DIAGNOSIS
Primary Diagnosis: Guillain-Barré Syndrome - Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
Brighton Criteria for GBS Diagnosis (Level 1 - Highest certainty):
- Bilateral flaccid limb weakness ✓
- Decreased/absent deep tendon reflexes in weak limbs ✓
- Monophasic illness, interval between onset nadir 12 hours - 28 days ✓
- CSF protein above normal, CSF cell count <50 cells/mm³ ✓
- Electrodiagnostic evidence of polyneuropathy ✓
- No alternative diagnosis ✓
PART 6 - PHYSIOTHERAPY ASSESSMENT (SUMMARY)
| Domain | Finding |
|---|
| Posture | Bed-bound, unable to maintain upright posture independently |
| ROM | Full passive ROM bilaterally; active ROM grossly limited |
| Muscle tone | Flaccid throughout (hypotonia) |
| Muscle strength | UL: 2-3/5 proximally, 0-2/5 distally; LL: 0-2/5 throughout |
| Sensation | Reduced light touch and proprioception in glove-stocking distribution |
| Pain | Neuropathic pain: 6/10 NRS at rest (burning, aching) |
| Respiratory | Mildly reduced chest expansion; adequate SpO2 on room air |
| Balance | Unable to assess standing balance (bed-bound) |
| Functional mobility | Fully dependent for all transfers; wheelchair dependent |
| ADL status | Fully/mostly dependent |
| Fatigue | Severe - limits exercise tolerance |
PART 7 - PHYSIOTHERAPY GOALS
SHORT-TERM GOALS (Weeks 1-4)
- Prevent secondary complications - avoid contractures, pressure ulcers, DVT, aspiration pneumonia, and disuse atrophy
- Maintain full passive range of motion in all joints of all four limbs
- Reduce neuropathic pain to ≤4/10 on NRS through positioning, TENS, and gentle handling
- Improve respiratory function - maintain SpO2 ≥95%, improve chest expansion, facilitate secretion clearance
- Maintain/improve muscle activation - achieve active contraction (grade 1-2 → 2-3/5) in proximal muscles through assisted active exercises
- Maintain skin integrity - pressure ulcer prevention protocol
- Improve sitting tolerance - from 0 to 15-30 minutes in supported sitting
- Educate patient and family regarding positioning, handling, and home program
- Prevent foot drop / wrist drop through appropriate splinting and positioning
- Improve fatigue management - energy conservation strategies
LONG-TERM GOALS (Weeks 4-12 and beyond)
- Restore functional ambulation - progress from bed-bound → sitting → standing with support → ambulation with walking aid → independent ambulation
- Achieve full or near-full muscle strength (grade 4-5/5 in all muscle groups)
- Restore normal gait pattern - address foot drop, trunk stability, and endurance
- Achieve independence in ADLs - dressing, bathing, grooming, toileting
- Return to occupation/previous activity level
- Normalize sensory processing - proprioception and balance retraining
- Maximize cardiorespiratory fitness - aerobic conditioning program
- Achieve community ambulation (walking ≥500 m outdoors, stairs, ramps)
- Improve Hughes Disability Scale from Grade 4 → Grade 1 or 0
- Improve FIM score from ~45 → 110-126 (near-independence)
- Psychological rehabilitation - address depression, anxiety, and return-to-life confidence
PART 8 - PHYSIOTHERAPY TREATMENT PLAN
SHORT-TERM TREATMENT PLAN (Acute Phase - Weeks 1-4)
Phase 1: Acute/Progressive Phase (1-3 weeks)
1. Positioning and Pressure Care
- 2-hourly position changes (supine, side-lying, semi-fowler's)
- Limb positioning: pillows under calves (heel protection), foot boards to prevent plantarflexion contracture
- Anti-pressure mattress / alternating air mattress
- Wrist splints (cock-up position) to prevent wrist drop
- Ankle-foot orthosis (AFO) or resting foot splints to prevent foot drop
2. Passive Range of Motion Exercises (PROME)
- All joints of bilateral upper and lower limbs
- Frequency: 2x daily, 10 repetitions per joint
- Gentle, pain-free, full range
- Key joints: shoulder, elbow, wrist, MCP/PIP; hip, knee, ankle, subtalar
- Special attention to: ankle dorsiflexion, hip external rotation, shoulder abduction
3. Respiratory Physiotherapy
- Deep breathing exercises (diaphragmatic + segmental)
- Manual assisted cough technique / splinted cough
- Incentive spirometry
- Postural drainage + percussion if secretions present
- Monitor FVC daily; spirometry for trend
- Semi-recumbent positioning (30-45°) at all times to prevent aspiration
- Suction if required
4. Pain Management
- Transcutaneous Electrical Nerve Stimulation (TENS) - conventional mode (80-100 Hz, 100 μs) for neuropathic pain
- Hydrotherapy (warm water immersion if tolerated)
- Gentle massage to painful limbs
- Comfortable positioning with limb support
- Consultation with medical team for pharmacological adjuncts (gabapentin)
5. Early Motor Re-education
- Assisted active exercises (physiotherapist-assisted or gravity-eliminated)
- PNF facilitation techniques - rhythmic initiation, repeated contractions
- Electrical stimulation (Neuromuscular Electrical Stimulation - NMES / FES) to denervated/weak muscles
- Focus on proximal muscles first (shoulder abductors, hip flexors)
- Muscle re-education with biofeedback if available
6. DVT Prophylaxis
- Ankle pumps / foot and ankle PROME every 2 hours
- Compression stockings / pneumatic compression devices
- Early mobilization as tolerated
7. Cognitive and Psychological Support
- Daily communication and reassurance
- Explanation of prognosis (85-90% recover to independent walking by 6-12 months)
- Mindfulness / relaxation techniques
- Referral to psychologist / counselor if anxiety/depression present
LONG-TERM TREATMENT PLAN (Recovery Phase - Weeks 4-24+)
Phase 2: Plateau/Early Recovery Phase (Weeks 4-8)
1. Progressive Strengthening
- Active assisted exercises → Active exercises → Resisted exercises (progressive resistance)
- MRC-guided progression: Advance exercise when grade ≥3/5
- Free weights, Theraband, pulley systems
- Focus: quadriceps, hip extensors/abductors, dorsiflexors, intrinsic foot muscles
- Aquatic physiotherapy / hydrotherapy: Buoyancy-assisted active exercises, walking in pool
2. Balance and Proprioception Training
- Sitting balance progression: supported → unsupported → perturbed
- Standing balance: parallel bars → standing frame → standing with fingertip support
- Proprioceptive training: foam pads, wobble boards, BAPS board
- Functional reaching tasks in sitting and standing
- Mirror visual feedback for proprioceptive impairment
3. Gait Re-education
- Standing practice: parallel bars, tilt table for gradual weight-bearing
- Tilt table: 0° → 30° → 60° → 80° incremental tilting
- Gait training: parallel bars → rollator walker → forearm crutches → walking stick → independent
- Address foot drop: AFO use during ambulation, FES to ankle dorsiflexors during gait
- Gait pattern correction: step length, cadence, trunk control, arm swing
4. Functional Task Training (ADL Rehabilitation)
- Bed mobility: rolling, supine-to-sit transfers
- Transfer training: sit-to-stand, toilet transfers, car transfers
- ADL practice: dressing (upper and lower body), grooming, bathing, cooking
- Wheelchair mobility training if ambulation not yet possible
- Stair climbing training (when quadriceps ≥4/5)
5. Cardiorespiratory Endurance Training
- Cycle ergometer (upper/lower limb) - start at low resistance, short duration (5-10 min)
- Progressive aerobic conditioning: increase duration by 5 minutes/week
- Target: 20-30 minutes of moderate-intensity aerobic exercise
- Monitor heart rate, blood pressure (autonomic lability)
- Swimming / hydrotherapy pool ambulation as aerobic activity
6. Upper Limb Rehabilitation
- Fine motor skills: pegboard activities, handwriting, pinch/grip strengthening
- Functional hand activities: buttoning, opening jars, typing
- Sensory re-education: texture discrimination, graded sensory input
- Occupation-specific training as per patient's job/hobbies
7. Community Reintegration
- Outdoor walking on uneven terrain, curbs, slopes
- Public transport usage training
- Driving assessment (when appropriate)
- Work simulation tasks
- Home modification advice (grab rails, raised toilet seat, shower chair)
8. Splinting / Orthotic Management
- Wean off resting splints as strength returns
- Transition from rigid AFO → hinged AFO → no AFO as dorsiflexion recovers
- Serial splinting for any residual contracture
9. Home Exercise Program (HEP)
- Written and demonstrated home program
- Progressive theraband exercises, walking program
- Family/caregiver training
- Tele-rehabilitation follow-up
PART 9 - OUTCOME MEASURES
| Outcome Measure | Assessment Timing |
|---|
| MRC Sum Score (total 60) | Admission, weekly, discharge, 3/6/12 months |
| Hughes Disability Scale (0-6) | Admission, discharge, follow-up |
| Functional Independence Measure (FIM) | Admission, discharge, 3 months |
| Barthel Index | Weekly during recovery |
| Timed Up and Go (TUG) | When ambulatory (target <12 seconds) |
| 6-Minute Walk Test (6MWT) | When ambulatory |
| NRS Pain Score | Daily |
| Berg Balance Scale | When sitting/standing balance assessed |
| Fatigue Severity Scale (FSS) | Weekly |
| SF-36 / EQ-5D | Admission, discharge, 6 months (QoL) |
| FVC / Peak Flow | Daily during acute phase |
PART 10 - PROGNOSIS
- ~85-90% of GBS patients regain independent walking by 6-12 months
- ~5-10% have residual disability at 3 years
- Poor prognostic factors: age >60 years, rapid progression (<7 days to nadir), need for ventilation, severe axonal involvement on NCS (AMAN/AMSAN > AIDP), low CMAP amplitudes
- GBS-related fatigue may persist for years even after motor recovery
- Recurrence rare (~1-3% annual risk of CIDP developing)
Note: The PDF provided was a scanned image-based document. The tools available in this session (OCR, vision analysis) were unable to read the exact text from the scan due to technical constraints (no Tesseract OCR installed, local file URLs not accessible to media analysis tools). The framework above is a clinically complete and accurate GBS physiotherapy case presentation that covers all the exact categories you asked for. To personalize it with the specific patient's name, age, exact MRC grades, NCS values, and CSF findings from your PDF, please type out or share those key details and I will incorporate them precisely.
You can reply with "continue" to resume with a fresh budget - I can then attempt further image extraction using different methods to pull the exact patient-specific data from your PDF and fill in all the patient-specific fields above.